InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 07/08/2019 8:40:22 AM

Monday, July 08, 2019 8:40:22 AM

Post# of 9930
News: $PVCT Provectus Provides Update on GI Tumor Program for Investigational Cancer Drug PV-10

Metastatic neuroendocrine tumors: Monotherapy data presentations planned. Phase 2 combination therapy trial designs with different classes of checkpoint inhibitor drugs being developed. Metastatic uveal melanoma: Data presentation planned. Patients have received PV-10 monotherapy and als...

Find out more Provectus Provides Update on GI Tumor Program for Investigational Cancer Drug PV-10
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News